Trefoil Therapeutics
Phase 2We are dedicated to restoring sight to the millions of people with corneal diseases through the advancement of therapies based on the inherent regenerative properties of naturally occurring corneal endothelial and epithelial cells.
Founded
2012
Focus
Small Molecules
About
We are dedicated to restoring sight to the millions of people with corneal diseases through the advancement of therapies based on the inherent regenerative properties of naturally occurring corneal endothelial and epithelial cells.
Funding History
3Total raised: $96M
Series B$59MFidelity Management & Research CompanyNov 15, 2022
Series A$32MVersant VenturesOct 15, 2020
Seed$5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2012
LocationSan Diego, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile